Intuitive Surgical, Inc. $ISRG Shares Sold by Verde Servicos Internacionais S.A.

Verde Servicos Internacionais S.A. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 44.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,544 shares of the medical equipment provider’s stock after selling 9,842 shares during the quarter. Intuitive Surgical comprises 1.7% of Verde Servicos Internacionais S.A.’s portfolio, making the stock its 20th largest holding. Verde Servicos Internacionais S.A.’s holdings in Intuitive Surgical were worth $5,101,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. 3Chopt Investment Partners LLC raised its position in shares of Intuitive Surgical by 5.2% in the first quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider’s stock valued at $213,000 after purchasing an additional 23 shares during the period. Beaumont Financial Advisors LLC boosted its holdings in Intuitive Surgical by 3.8% during the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after acquiring an additional 23 shares during the period. W.G. Shaheen & Associates DBA Whitney & Co increased its stake in shares of Intuitive Surgical by 1.0% in the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after purchasing an additional 25 shares during the period. Blue Fin Capital Inc. lifted its position in shares of Intuitive Surgical by 0.5% during the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after purchasing an additional 25 shares during the last quarter. Finally, Red Spruce Capital LLC lifted its position in shares of Intuitive Surgical by 4.1% during the 2nd quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after purchasing an additional 25 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, SVP Patricia Wadors sold 1,078 shares of the company’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 20,095 shares of the firm’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the transaction, the director directly owned 1,204,530 shares of the company’s stock, valued at approximately $543,977,793.30. This trade represents a 1.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 38,684 shares of company stock worth $16,770,301 in the last three months. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ISRG. Oppenheimer reiterated an “outperform” rating and set a $500.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $513.00 to $550.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 21st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Royal Bank Of Canada cut their target price on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research note on Wednesday, October 21st. Finally, Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Price Performance

ISRG stock opened at $445.88 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The business’s 50-day simple moving average is $398.31 and its 200 day simple moving average is $436.15.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. The company’s revenue was up 21.7% on a year-over-year basis. During the same period last year, the company earned $2.40 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly constructive: the average brokerage recommendation is equivalent to a Buy, while the reported consensus price target of $493.54 is above recent trading levels. However, the article cautions that sell-side ratings can be overly optimistic. Wall Street bullish views on ISRG
• Positive Sentiment: Analysts have been raising earnings estimates, and Zacks highlighted ISRG’s growth profile. The company’s latest quarterly results provide fundamental support, with revenue up 21.7% year over year to $3.05 billion and earnings of $3.00 per share versus a $2.65 consensus estimate. Higher earnings estimates
• Neutral Sentiment: ISRG is attracting substantial investor attention, which may increase trading activity but does not necessarily signal a change in business fundamentals. Reported short interest of zero shares and a zero-day days-to-cover ratio also appear inconsistent with the description of a significant increase, limiting the data’s usefulness. ISRG trending-stock analysis
• Negative Sentiment: Several insiders sold shares under pre-arranged Rule 10b5-1 plans. Director Gary Guthart sold approximately $9.1 million, while a vice president, senior vice president and another director also reduced their holdings. Although planned sales are not necessarily bearish, the cluster may weigh on sentiment. ISRG insider selling
• Negative Sentiment: Valuation remains a key risk. ISRG trades at roughly 54 times earnings and a PEG ratio above 3, leaving limited room for execution disappointments. The stock’s decline below its 200-day moving average may also indicate near-term technical weakness.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.